γ‐Secretase Dependent Nuclear Targeting of Dystroglycan

Article English OPEN
Leocadio, Daniel ; Mitchell, Andrew ; Winder, Steve J. (2016)
  • Publisher: John Wiley and Sons Inc.
  • Journal: Journal of Cellular Biochemistry (issn: 0730-2312, vol: 117, pp: 2,149-2,157)
  • Related identifiers: pmc: PMC4982099, doi: 10.1002/jcb.25537
  • Subject: PROSTATE CANCER | DYSTROGLYCAN | Articles | Article | PROTEOLYSIS
    mesheuropmc: congenital, hereditary, and neonatal diseases and abnormalities | fungi | musculoskeletal system | animal structures | musculoskeletal diseases

ABSTRACT Dystroglycan is frequently lost in adenocarcinoma. α‐dystroglycan is known to become hypoglycosylated due to transcriptional silencing of LARGE, whereas β‐dystroglycan is proteolytically cleaved and degraded. The mechanism and proteases involved in the cleavage events affecting β‐dystroglycan are poorly understood. Using LNCaP prostate cancer cells as a model system, we have investigated proteases and tyrosine phosphorylation affecting β‐dystroglycan proteolysis and nuclear targeting. Cell density or phorbol ester treatment increases dystroglycan proteolysis, whereas furin or γ‐secretase inhibitors decreased dystroglycan proteolysis. Using resveratrol treatment of LNCaP cells cultured at low cell density in order to up‐regulate notch and activate proteolysis, we identified significant increases in the levels of a 26 kDa β‐dystroglycan fragment. These data, therefore, support a cell density‐dependent γ‐secretase and furin mediated proteolysis of β‐dystroglycan, which could be notch stimulated, leading to nuclear targeting and subsequent degradation. 117: 2149–2157, 2016. © 2016 The Authors. Journal of Cellular Biochemistry Published by Wiley Periodicals, Inc.
  • References (51)
    51 references, page 1 of 6

    Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM. 2006. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 203:1007-1019.

    Armstrong SC, Latham CA, Ganote CE. 2003. An ischemic b-dystroglycan degradation product: Correlation with irreversible injury in adult rabbit cardiomyocytes. Mol Cell Biochem 242:71-79.

    Bao X, Kobayashi M, Hatakeyama S, Angata K, Gullberg D, Nakayama J, Fukuda MN, Fukuda M. 2009. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.

    Proc Natl Acad Sci USA 106:12109-12114.

    Bozzi M, Inzitari R, Sbardell D, Monaco S, Pavoni E, Gioia M, Marini S, Morlacchi S, Sciandra F, Castagnola M, Giardina B, Brancaccio A, Coletta M. 2009. Enzymatic processing of b-dystroglycan recombinant ectodomain by MMP-9: Identification of the main cleavage site. IUBMB Life 61:1143-1152.

    Cross S, Lippitt J, Mitchell A, Hollingsbury F, Balasubramanian S, Reed M, Eaton C, Catto J, Hamdy F, Winder S. 2008. The expression of b-dystroglycan is reduced or absent in the majority of human carcinomas. Histopathology 53:561-566.

    de Bernabe DB-V, Inamori K-I, Yoshida-Moriguchi T, Weydert CJ, Harper HA, Willer T, Henry MD, Campbell KP. 2009. Loss of a-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J Biol Chem 284:11279-11284.

    Esser AK, Miller MR, Huang Q, Meier MM, Beltran-Valero de Bernabe D, Stipp CS, Campbell KP, Lynch CF, Smith BJ, Cohen MB, Henry MD. 2013. Loss of LARGE2 disrupts functional glycosylation of alpha-dystroglycan in prostate cancer. J Biol Chem 288:2132-2142.

    Gooz M. 2010. ADAM-17: The enzyme that does it all. Crit Rev Biochem Mol Biol 45:146-169.

    Gould CM, Diella F, Via A, Puntervoll P, Gemund C, Chabanis-Davidson S, Michael S, Sayadi A, Bryne JC, Chica C, Seiler M, Davey NE, Haslam N, Weatheritt RJ, Budd A, Hughes T, Pas J, Rychlewski L, Trave G, Aasland R, Helmer-Citterich M, Linding R, Gibson TJ. 2010. ELM: The status of the 2010 eukaryotic linear motif resource. Nucleic Acids Res 38:D167-D180.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark